UBS AM
GDRX icon

UBS AM’s GoodRx Holdings GDRX Stock Holding History

UBS AM’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Sell
161,348
-3,689
-2% -$9.38K ﹤0.01% 2565
2026
Q1 		$323K Buy
165,037
+61,736
+60% +$145K ﹤0.01% 2643
2025
Q4 		$280K Sell
103,301
-23,069
-18% -$75.7K ﹤0.01% 2425
2025
Q3 		$535K Sell
126,370
-99,902
-44% -$439K ﹤0.01% 2151
2025
Q2 		$1.13M Buy
226,272
+86,023
+61% +$374K ﹤0.01% 2362
2025
Q1 		$618K Sell
140,249
-9,696
-6% -$45.5K ﹤0.01% 2452
2024
Q4 		$697K Buy
149,945
+61,924
+70% +$340K ﹤0.01% 2480
2024
Q3 		$611K Sell
88,021
-85,926
-49% -$674K ﹤0.01% 2588
2024
Q2 		$1.36M Buy
173,947
+122,381
+237% +$906K ﹤0.01% 2206
2024
Q1 		$366K Buy
51,566
+9,250
+22% +$61.2K ﹤0.01% 2362
2023
Q4 		$284K Sell
42,316
-971
-2% -$5.47K ﹤0.01% 2431
2023
Q3 		$244K Buy
43,287
+19,810
+84% +$132K ﹤0.01% 2472
2023
Q2 		$147K Hold
23,477
– – ﹤0.01% 2605
2023
Q1 		$147K Buy
23,477
+971
+4% +$5.41K ﹤0.01% 2605
2022
Q4 		$105K Hold
22,506
– – ﹤0.01% 2493
2022
Q3 		$105K Buy
22,506
+5,706
+34% +$36K ﹤0.01% 2681
2022
Q2 		$99.5K Buy
+16,800
New +$187K ﹤0.01% 2649
2021
Q2 		– Sell
-6,619
Closed -$258K – 2764
2021
Q1 		$258K Hold
6,619
– – ﹤0.01% 2514
2020
Q4 		$267K Buy
+6,619
New +$304K ﹤0.01% 2438

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS AM's GDRX Position: Q2 2026 in Review

UBS AM reduced its GoodRx Holdings (GDRX) stake by 2.2% in Q2 2026, selling an estimated $9.38K and leaving 161,348 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

UBS AM first reported a position in GDRX in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.36M in Q2 2024. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • UBS AM held 161,348 shares of GoodRx Holdings worth $465K as of Q2 2026.
  • UBS AM sold 3,689 GoodRx Holdings shares in Q2 2026, an estimated $9.38K.
  • GoodRx Holdings made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2565 holding.
  • UBS AM first reported a position in GoodRx Holdings in Q4 2020 and has held it in 19 quarters since.
  • UBS AM's GoodRx Holdings position peaked at $1.36M in Q2 2024.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.